Excess Foreign Flu Vaccine Supply Could Add 6 Mil. Doses To U.S.
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA hopes that some or all of the excess foreign flu vaccine will be available for U.S. use by year-end, FDA Acting Commissioner Crawford tells Senate subcommittee. FDA should finish reviewing 750,000 doses of foreign vaccine purchased through distribution channels by cities and states in two to three weeks, Crawford says.
You may also be interested in...
FDA Relying On Pedigree Info To Authorize Use Of Imported Flu Vaccine
FDA is relying on confirmed lot numbers and pedigree information to authorize the use of Sanofi-Aventis' Fluzone purchased directly from European distributors by state and local governments
FDA Relying On Pedigree Info To Authorize Use Of Imported Flu Vaccine
FDA is relying on confirmed lot numbers and pedigree information to authorize the use of Sanofi-Aventis' Fluzone purchased directly from European distributors by state and local governments
ID Biomedical Has 1.2 Mil. Extra Doses Of Fluviral For This Season
ID Biomedical will be able to provide 1.2 mil. additional doses of its flu vaccine Fluviral for this flu season, CEO Tony Holler said Dec. 6